Cell and Gene Manufacturing and Logistics
-
Leverage Bioreactor Capacity When You Need It With Culture Bioreactors
4/24/2024
Gain access to Culture bioreactors when you need rapid overflow experimental capacity.
Benefits
Progress studies faster
Run overflow projects and conduct parallel experiments with Culture to reduce time and alleviate bottlenecks.
Stay agile in your capacity planning
Scale your workload at Culture according to your current needs. Respond rapidly to surging demands.
Eliminate your capital equipment spend
Leverage Culture’s facility quickly to avoid building out lab space, spending capital on equipment, and hiring specialized staff.
-
Mitigating Human Error In The Cell Therapy Supply Chain
4/24/2024
There are a lot of moving parts involved in bringing stem-cell derived therapies to patients, and thus, many points where things can go south.
-
NK Cell Therapies: How Artiva Biotherapeutics Leverages Its “Manufacturing First” Approach
4/24/2024
We caught up with Chris Horan, Artiva Biotherapeutics' CTO, to discuss natural killer cell therapies and Artiva’s experiences and strategies with its candidate, AlloNK.
-
Bridging The Gap: Partnerships Driving Cell Therapy Development
4/24/2024
Delve into the dynamic transition towards automation in cell and gene therapy manufacturing as well as the challenges it presents to start ups with industry experts in this webinar.
-
Improving Governance And Compliance With Knowledge Management
4/23/2024
Knowledge management — it’s not just a soulless exercise. In the last part of his series, Hirsh helps bridge the gap between compliance and business needs.
-
Analytical Considerations For mRNA-Based Therapies
4/22/2024
Uncover why leveraging strong scientific expertise and comprehensive testing techniques will be vital in expediting development and upholding the integrity of these life-saving treatments.
-
Navigating Complex Testing For Viral Vector-Based Gene Therapies
4/22/2024
To ensure the success of gene therapy, learn why it is crucial to partner with a CRO that can navigate the challenges of viral vector development and testing.
-
AAV Analytics With Mass Photometry
4/22/2024
Explore why mass photometry is particularly well suited to working with adeno-associated viruses (AAVs) along with some solutions for AAV analysis.
-
Greener Detergents For Biopharmaceutical Applications
4/22/2024
Explore a portfolio of best-in-class detergent alternatives to Triton™ X-100 for use in biomanufacturing applications.
-
The Biggest Challenges Of Bioprocessing And How to Overcome Them
4/22/2024
Dr. Kris Tyner shares his experience and thoughts on simplifying bioprocessing, gathering answer faster, and de-risking while scaling up.